ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.849,63
-0,36%
S&P 500
5.652,46
0,38%
US Dollar vs BRL
5,45594
0,14%
Bitcoin
64.496,34
-0,55%
Brent Oil
83,35
-1,17%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Nightstar Therapeutics Plc ADS (NITE)

  7. Nightstar Therapeutics Plc ADS (NITE) Notícias

NITE

Nightstar Therapeutics Plc ADS (NITE)

Nightstar Therapeutics Plc ADS
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NITE
DataHoraFonteTítuloCódigoCompanhia
02/10/201717:05GlobeNewswire Inc.Nightstar Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Ame...NASDAQ:NITENightstar Therapeutics Plc ADS
28/09/201719:03GlobeNewswire Inc.Nasdaq Welcomes Nightstar Therapeutics Nightstar plc (Nasdaq: NITE) to The Nasdaq Stock MarketNASDAQ:NITENightstar Therapeutics Plc ADS
28/09/201707:00GlobeNewswire Inc.Nightstar Therapeutics (Nasdaq: NITE) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPONASDAQ:NITENightstar Therapeutics Plc ADS
27/09/201720:45Business WireNightstar Announces Pricing of Initial Public OfferingNASDAQ:NITENightstar Therapeutics Plc ADS
20/05/201017:03Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)NASDAQ:NITENightstar Therapeutics Plc ADS
20/05/201011:50PR Newswire (US)Knight Capital Group Comments on Contributions to Stabilize the U.S. Equity Markets in Response to the Plunge on May 6, 2010NASDAQ:NITENightstar Therapeutics Plc ADS
18/05/201007:05Business WireHoulihan Lokey and Knight Form Joint Marketing AllianceNASDAQ:NITENightstar Therapeutics Plc ADS
17/05/201019:08Dow Jones NewsHoulihan Lokey, Knight Capital To Join ForcesNASDAQ:NITENightstar Therapeutics Plc ADS
17/05/201017:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NITENightstar Therapeutics Plc ADS
14/05/201017:10Edgar (US Regulatory)Form 13F Holdings Report (13F-HR)NASDAQ:NITENightstar Therapeutics Plc ADS
14/05/201010:02Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NITENightstar Therapeutics Plc ADS
14/05/201008:30PR Newswire (US)Knight Capital Group Releases April 2010 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
12/05/201013:30PR Newswire (US)Knight Capital Group to Transfer Listing to NYSE, Cross-List on NYSE EuronextNASDAQ:NITENightstar Therapeutics Plc ADS
10/05/201014:37Dow Jones NewsNYSE CEO, CBOE CEO, Exchange Officials Decline To TalkNASDAQ:NITENightstar Therapeutics Plc ADS
10/05/201008:30PR Newswire (US)Knight Capital Group to Conduct Live Webcast of Annual Meeting for Shareholders on Wednesday, May 12, 2010NASDAQ:NITENightstar Therapeutics Plc ADS
07/05/201016:20Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NITENightstar Therapeutics Plc ADS
05/05/201014:45PR Newswire (US)UNX Adds Direct Access to Knight's Electronic Trading Services, Smart-Order Routing and Algorithms Through Catalyst(R) Portal anNASDAQ:NITENightstar Therapeutics Plc ADS
21/04/201008:30PR Newswire (US)Knight Capital Group Releases March 2010 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
21/04/201007:00PR Newswire (US)Knight Capital Group Announces Consolidated Earnings of $0.30 per Diluted Share for the First Quarter 2010NASDAQ:NITENightstar Therapeutics Plc ADS
20/04/201004:00PR Newswire (US)Knight Launches Oasis Small- and Mid-Cap Algorithm for European EquitiesNASDAQ:NITENightstar Therapeutics Plc ADS
12/04/201004:00PR Newswire (US)Knight Appoints Didier Bankole Vice President of Sales for the Electronic Trading Group in EuropeNASDAQ:NITENightstar Therapeutics Plc ADS
07/04/201016:53Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NITENightstar Therapeutics Plc ADS
30/03/201008:30PR Newswire (US)Knight Capital Group to Acquire Urban Financial GroupNASDAQ:NITENightstar Therapeutics Plc ADS
17/03/201005:00PR Newswire (US)Knight Libertas to Host Credit Opportunities Conference on March 25 in LondonNASDAQ:NITENightstar Therapeutics Plc ADS
16/03/201008:15PR Newswire (US)Knight Capital Group Announces Pricing of $325 Million of Cash Convertible Senior Subordinated NotesNASDAQ:NITENightstar Therapeutics Plc ADS
15/03/201018:33Dow Jones NewsBATS Warns Against Blanket Regulation For Off-Exchange TradeNASDAQ:NITENightstar Therapeutics Plc ADS
15/03/201004:01PR Newswire (US)Knight Capital Group Announces Proposed Offering of $300 Million of Cash Convertible Senior Subordinated NotesNASDAQ:NITENightstar Therapeutics Plc ADS
12/03/201019:29Dow Jones News2nd UPDATE: Direct Edge Wins Exchange Status From SECNASDAQ:NITENightstar Therapeutics Plc ADS
12/03/201019:08Dow Jones NewsUPDATE: Direct Edge Wins Exchange Status From SECNASDAQ:NITENightstar Therapeutics Plc ADS
12/03/201009:30PR Newswire (US)Knight Capital Group Releases February 2010 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
 Apresentando as notícias mais relevantes sobre:NASDAQ:NITE

Seu Histórico Recente

AQSE
IPRV.GB
iShares Listed Private E...
BIT
P1HXA8
BNP Paribas Issuance
BIT
FDIVER
Vontobel Financial Produ...
BIT
P1VRG8
NLBNPIT1VRG8 20351221 11...
BIT
DES2
L&G DAX Daily 2x Short U...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados